AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (June 22, 2007). doi:10.1152/ajpheart.00493.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/3/H1892    most recent
00493.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shinohara, T.
Right arrow Articles by Yoshimatsu, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shinohara, T.
Right arrow Articles by Yoshimatsu, H.
Submitted on April 24, 2007
Accepted on June 19, 2007

Mitochondria are targets for geranylgeranylacetone-induced cardioprotection against ischemia/reperfusion in the rat heart

Tetsuji Shinohara1*, Naohiko Takahashi2, Hiroaki Kohno2, Kunitoshi Yamanaka2, Tatsuhiko Ooie3, Osamu Wakisaka1, Yukichi Murozono1, Yayoi Taniguchi4, Yasuko Torigoe4, Masahide Hara2, Tatsuo Shimada5, Tetsunori Saikawa3, and Hironobu Yoshimatsu2

1 Department of Internal Medicine 1, Faculty of Medicine, Oita University, Yuhu, Oita, Japan
2 Department of Internal Medicine 1, Faculty of Medicine, Oita University, Hasama, Oita, Japan
3 Department of Cardiovascular Science, Faculty of Medicine, Oita University, Hasama, Oita, Japan
4 Department of Cardiovascular Science, Faculty of Medicine, Oita University, Yuhu, Oita, Japan
5 Department of Health Science, School of Nursing, Oita University, Hasama, Oita, Japan

* To whom correspondence should be addressed. E-mail: shinohar{at}med.oita-u.ac.jp.

It has been shown that orally administered geranylgeranylacetone (GGA), an anti-ulcer drug, induces expression of heat shock protein 72 (HSP72) and provides protection against ischemia/reperfusion in rat hearts. The underlying protective mechanisms, however, remain unknown. Mitochondria have been shown to be a selective target for heat-stress (HS)-induced cardioprotection. Therefore, we hypothesized that preservation of mitochondrial function, owing to opening of a putative channel in the inner mitochondrial membrane, the mitochondrial adenosine-triphosphate (ATP)-sensitive potassium (mitoKATP) channel, could be involved in GGA- or HS-induced cardioprotection against ischemia/reperfusion. Rats were treated with oral GGA or vehicle. Twenty-four hours later, each heart was isolated and perfused with a Langendorff apparatus. GGA-treated hearts showed better functional recovery and less creatine kinase was released during a 30-minute reperfusion period, after 20 minutes of no-flow ischemia. Concomitant perfusion with 5-hydroxydecanoate (5HD, 100 µM) or glibenclamide (10 µM) abolished the GGA-induced cardioprotective effect. GGA also showed preserved mitochondrial respiratory function, isolated at the end of the reperfusion period, which was abolished with 5HD treatment. GGA prevented destruction of the mitochondrial structure by ischemia/reperfusion, as shown by electron microscopy. In cultured cardiomyocytes, GGA induced HSP72 expression and resulted in less damage to cells, including less apoptosis in response to hypoxia/reoxygenation. Treatment with 5HD abolished the GGA-induced cardioprotective effects, but did not affect HSP72 expression. Our results indicate that preserved mitochondrial respiratory function, owing to GGA-induced HSP72 expression, may, at least in part, have a role in cardioprotection against ischemia/reperfusion. These processes may involve opening of the mitoKATP channel.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
P. S. Pagel
Induction of Heat Shock Protein 70 and Preconditioning by Sevoflurane: A Potent Protective Interaction Against Myocardial Ischemia-Reperfusion Injury
Anesth. Analg., September 1, 2008; 107(3): 742 - 745.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
H. Kitahata, J. Nozaki, S. Kawahito, T. Tomino, and S. Oshita
Low-Dose Sevoflurane Inhalation Enhances Late Cardioprotection from the Anti-Ulcer Drug Geranylgeranylacetone
Anesth. Analg., September 1, 2008; 107(3): 755 - 761.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. J.J.M. Brundel, L. Ke, A.-J. Dijkhuis, X. Qi, A. Shiroshita-Takeshita, S. Nattel, R. H. Henning, and H. H. Kampinga
Heat shock proteins as molecular targets for intervention in atrial fibrillation
Cardiovasc Res, June 1, 2008; 78(3): 422 - 428.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.